"アジュバント" の関連情報検索結果
Adverse events of postoperative adjuvant chemotherapy predict survival outcomes in locally advanc...

Adjuvant vs Neoadjuvant Therapy for Resectable NSCLC - Medscape

Adjuvant vs Neoadjuvant Therapy for Resectable NSCLC Medscape
An adjuvant database for preclinical evaluation of vaccines and immunotherapeutics - ScienceDirec...

An adjuvant database for preclinical evaluation of vaccines and immunotherapeutics ScienceDirect.com
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer - NEJM

Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer NEJM
Long-Term Follow-Up of Real-World Adjuvant Anti–PD-1 Checkpoint Inhibition and Targeted Therapy i...

Long-Term Follow-Up of Real-World Adjuvant Anti–PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma ASCO Publications
Novel Flu Vaccine Adjuvant Improves Protection Against Influenza Viruses, Study Finds - Georgia S...

Novel Flu Vaccine Adjuvant Improves Protection Against Influenza Viruses, Study Finds Georgia State University News
Linking vaccine adjuvant mechanisms of action to function - Science | AAAS

Linking vaccine adjuvant mechanisms of action to function Science | AAAS
Shell ondina x as animal vaccine adjuvant - Shell Global

Shell ondina x as animal vaccine adjuvant Shell Global
ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Co...

ASCO 2025: Adding Atezolizumab to Adjuvant Chemotherapy Improves Disease-Free Survival in dMMR Colon Cancer The ASCO Post
ASCO GU 2025: Adjuvant Therapy in Renal Cell Cancer: A Practical Guide - UroToday

ASCO GU 2025: Adjuvant Therapy in Renal Cell Cancer: A Practical Guide UroToday
Matrix-M adjuvant triggers inflammasome activation and enables antigen cross-presentation through...

A fungal-derived adjuvant amplifies the antitumoral potency of Bacillus Calmette-Guérin via repro...

A fungal-derived adjuvant amplifies the antitumoral potency of Bacillus Calmette-Guérin via reprogramming granulopoiesis ScienceDirect.com
Trends in the use and efficacy of adjuvant immunotherapy in muscle-invasive urothelial carcinoma ...

Trends in the use and efficacy of adjuvant immunotherapy in muscle-invasive urothelial carcinoma Nature
Lipid nanoparticles with prazole adjuvant to enhance the efficacy of mRNA cancer vaccines - Scien...

Lipid nanoparticles with prazole adjuvant to enhance the efficacy of mRNA cancer vaccines ScienceDirect.com
Adjuvant icotinib for resected EGFR-mutated stage II–IIIA non-small-cell lung cancer (ICTAN, GAST...

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR -mutated stage IB–II...

Determining the optimal duration of oral adjuvant chemotherapy in locoregionally advanced nasopha...

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes...

A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae ...

Calboxyvinyl polymer adjuvant enhances respiratory IgA responses through mucosal and systemic adm...

Adjuvant Therapy for Breast Cancer: Practice Essentials, Overview, Combination Regimens for Breas...

ASCO GU 2025: Discussant: Adjuvant Immunotherapy in High Risk Muscle Invasive Bladder Cancer - Ur...

ASCO GU 2025: Discussant: Adjuvant Immunotherapy in High Risk Muscle Invasive Bladder Cancer UroToday
Strong immune responses and robust protection following a novel protein in adjuvant tuberculosis ...

Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as mol...

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival a...

Adjuvant Osimertinib in EGFR-Mutated NSCLC: The Survival Curves Reveal the Next Set of Questions ...

Adjuvant Osimertinib in EGFR-Mutated NSCLC: The Survival Curves Reveal the Next Set of Questions on How to Optimize Benefits ASCO Daily News
Multimodal data integration for biologically-relevant artificial intelligence to guide adjuvant c...

SUO 2024: Adjuvant Systemic Therapy in Urothelial Carcinoma: Where Are We At Today? - UroToday

SUO 2024: Adjuvant Systemic Therapy in Urothelial Carcinoma: Where Are We At Today? UroToday
Role of ICIs in Adjuvant MSI-H CRC: Hope or Hype? - ASCO Daily News

Role of ICIs in Adjuvant MSI-H CRC: Hope or Hype? ASCO Daily News
Saponin-based adjuvant uptake and induction of antigen cross-presentation by CD11b+ dendritic cel...

C-POST: Adjuvant Cemiplimab Reduces Risk of Recurrence in Patients With High-Risk Cutaneous Squam...

C-POST: Adjuvant Cemiplimab Reduces Risk of Recurrence in Patients With High-Risk Cutaneous Squamous Cell Carcinoma ASCO Daily News
Dual-Functional Antibiotic Adjuvant Displays Potency against Complicated Gram-Negative Bacterial ...

Dual-Functional Antibiotic Adjuvant Displays Potency against Complicated Gram-Negative Bacterial Infections and Exhibits Immunomodulatory Properties ACS Publications
Adjuvant chemotherapy and hormonotherapy versus adjuvant hormonotherapy alone for women aged 70 y...

Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an internat...

Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a ...

Adjuvant Nivolumab Plus Chemoradiotherapy Meets DFS End Point in Locally Advanced HNSCC - OncLive

Adjuvant Nivolumab Plus Chemoradiotherapy Meets DFS End Point in Locally Advanced HNSCC OncLive
Methods of saponin purification from Quillaja sp. for vaccine adjuvant production - Frontiers

Methods of saponin purification from Quillaja sp. for vaccine adjuvant production Frontiers
Adjuvant Cemiplimab Improves DFS in High-Risk Cutaneous Squamous Cell Carcinoma - OncLive

Adjuvant Cemiplimab Improves DFS in High-Risk Cutaneous Squamous Cell Carcinoma OncLive
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized ...

Adjuvant endocrine treatment strategies for non-metastatic breast cancer: a network meta-analysis...

Adjuvant endocrine treatment strategies for non-metastatic breast cancer: a network meta-analysis The Lancet
Adjuvant T-DM1 in Patients With HER2-Positive Breast Cancer: Long-Term Results of the KATHERINE T...

Adjuvant T-DM1 in Patients With HER2-Positive Breast Cancer: Long-Term Results of the KATHERINE Trial The ASCO Post
Spleen-Targeted mRNA Vaccine Doped with Manganese Adjuvant for Robust Anticancer Immunity In Vivo...

Spleen-Targeted mRNA Vaccine Doped with Manganese Adjuvant for Robust Anticancer Immunity In Vivo ACS Publications
Survival benefit added by adjuvant chemotherapy in adenoid cystic carcinoma of salivary gland - N...

Survival benefit added by adjuvant chemotherapy in adenoid cystic carcinoma of salivary gland Nature
Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the rando...

Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a rand...

Novartis ribociclib (Kisqali®) recognized as Category 1 preferred breast cancer adjuvant treatmen...

Two-dimensional coordination risedronate-manganese nanobelts as adjuvant for cancer radiotherapy ...

Matcha Tea as Adjuvant Therapy Improves Gingival Health, suggests study - Medical Dialogues

Matcha Tea as Adjuvant Therapy Improves Gingival Health, suggests study Medical Dialogues
ASTRO 2024: Bladder Adjuvant RadioTherapy (BART): Acute and Late Toxicity from a Phase III Multic...

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma - NEJM

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma NEJM
An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expand...

An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity ScienceDirect.com
Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer - NEJM

Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer NEJM
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma - NEJM

Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma NEJM
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline U...

Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update ASCO Publications
Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3...

The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally de...

Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine - National Inst...

Adjuvant developed with NIH funding enhances efficacy of India’s COVID-19 vaccine National Institutes of Health (NIH) | (.gov)
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA v...

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer - NEJM

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer NEJM
The scientific journey of a novel adjuvant (AS37) from bench to bedside - Nature

The scientific journey of a novel adjuvant (AS37) from bench to bedside Nature
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma - NEJM

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma NEJM
Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal canc...

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer Nature
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma - Nature

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma Nature
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma - Nature

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma Nature
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma - NEJM

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma NEJM
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer - NEJM

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer NEJM
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF -Mutated Melanoma - NEJM

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF -Mutated Melanoma NEJM
Engineered immunogen binding to alum adjuvant enhances humoral immunity - Nature

Engineered immunogen binding to alum adjuvant enhances humoral immunity Nature
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma - NEJM

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma NEJM
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma - NEJM

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma NEJM
Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC -...

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC Nature
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy - NEJM

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy NEJM
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma - NEJM

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma NEJM
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma - NEJM

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma NEJM
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer - NEJM

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer NEJM
Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer - NEJM

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer NEJM
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer - NEJM

Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer NEJM
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer - NEJM

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer NEJM
Pembrolizumab Is First Adjuvant Therapy to Improve Overall Survival in Kidney Cancer - National C...

Pembrolizumab Is First Adjuvant Therapy to Improve Overall Survival in Kidney Cancer National Cancer Institute (.gov)
Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immun...

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer - NEJM

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer NEJM
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer - NEJM

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer NEJM
Human In vitro Modeling Identifies Adjuvant Combinations that Unlock Antigen Cross-presentation a...

Human In vitro Modeling Identifies Adjuvant Combinations that Unlock Antigen Cross-presentation and Promote T-helper 1 Development in Newborns, Adults and Elders ScienceDirect.com
A combined adjuvant approach primes robust germinal center responses and humoral immunity in non-...

Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort stu...

Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study Nature
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years - NEJM

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years NEJM
Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a popula...

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer - NEJM

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer NEJM
Adjuvant therapy options in renal cell carcinoma — targeting the metastatic cascade - Nature

Adjuvant therapy options in renal cell carcinoma — targeting the metastatic cascade Nature
A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of inf...

Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative bre...

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy - NEJM

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy NEJM
Neutrophil extracellular traps-inspired DNA hydrogel for wound hemostatic adjuvant - Nature

Neutrophil extracellular traps-inspired DNA hydrogel for wound hemostatic adjuvant Nature
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma - NEJM

Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma NEJM
AUA 2024: Risk Stratification for Adjuvant Therapy with High Risk RCC - UroToday

AUA 2024: Risk Stratification for Adjuvant Therapy with High Risk RCC UroToday
Human in vitro modeling of adjuvant formulations demonstrates enhancement of immune responses to ...

Vaccine adjuvant activity of a TLR4-activating synthetic glycolipid by promoting autophagy - Nature

Vaccine adjuvant activity of a TLR4-activating synthetic glycolipid by promoting autophagy Nature
Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast C...

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial ASCO Publications
Transdermal microneedles integrating biomimetic self-adjuvant particles for enhanced immunity - S...

Transdermal microneedles integrating biomimetic self-adjuvant particles for enhanced immunity ScienceDirect.com
Impact of surgery and adjuvant chemotherapy on the survival of stage I lung adenocarcinoma patien...

Impact of surgery and adjuvant chemotherapy on the survival of stage I lung adenocarcinoma patients with tumor spread through air spaces ScienceDirect.com